Designing a placebo device: Involving service users in clinical trial design
Authors: Gooberman-Hill, R., Jinks, C., Bouças, S.B., Hislop, K., Dziedzic, K.S., Rhodes, C., Burston, A. and Adams, J.
Journal: Health Expectations
Volume: 16
Issue: 4
eISSN: 1369-7625
ISSN: 1369-6513
DOI: 10.1111/hex.12043
Abstract:Background: Service users are increasingly involved in the design of clinical trials and in product and device development. Service user involvement in placebo development is crucial to a credible and acceptable placebo for clinical trials, but such involvement has not yet been reported. Aims: To enhance the design of a future clinical trial of hand splints for thumb-base osteoarthritis (OA), service users were involved in splint selection and design of a placebo splint. This article describes and reflects on this process. Design: Two fora of service users were convened in 2011. Service users who had been prescribed a thumb splint for thumb-base OA were approached about involvement by Occupational Therapy (OT) practitioners. Content of the fora: A total of eight service users took part in the fora. Service users discussed their experience of OA and their own splints and then tried a variety of alternative splints. Through this they identified the active features of splints alongside acceptable and unacceptable design features. Service users focused on wearability and support with or without immobilization. Fora discussed whether a placebo group ('arm') was an acceptable feature of a future trial, and service users developed a potential design for a placebo splint. Conclusion and discussion: This is the first project that to involve service users in placebo design. Service users are increasingly involved in product and device design and are ideally placed to identify features to make a placebo credible yet lacking key active ingredients. The future trial will include research into its acceptability. © 2013 John Wiley & Sons Ltd.
Source: Scopus
Designing a placebo device: involving service users in clinical trial design.
Authors: Gooberman-Hill, R., Jinks, C., Bouças, S.B., Hislop, K., Dziedzic, K.S., Rhodes, C., Burston, A. and Adams, J.
Journal: Health Expect
Volume: 16
Issue: 4
Pages: e100-e110
eISSN: 1369-7625
DOI: 10.1111/hex.12043
Abstract:BACKGROUND: Service users are increasingly involved in the design of clinical trials and in product and device development. Service user involvement in placebo development is crucial to a credible and acceptable placebo for clinical trials, but such involvement has not yet been reported. AIMS: To enhance the design of a future clinical trial of hand splints for thumb-base osteoarthritis (OA), service users were involved in splint selection and design of a placebo splint. This article describes and reflects on this process. DESIGN: Two fora of service users were convened in 2011. Service users who had been prescribed a thumb splint for thumb-base OA were approached about involvement by Occupational Therapy (OT) practitioners. CONTENT OF THE FORA: A total of eight service users took part in the fora. Service users discussed their experience of OA and their own splints and then tried a variety of alternative splints. Through this they identified the active features of splints alongside acceptable and unacceptable design features. Service users focused on wearability and support with or without immobilization. Fora discussed whether a placebo group ('arm') was an acceptable feature of a future trial, and service users developed a potential design for a placebo splint. CONCLUSION AND DISCUSSION: This is the first project that to involve service users in placebo design. Service users are increasingly involved in product and device design and are ideally placed to identify features to make a placebo credible yet lacking key active ingredients. The future trial will include research into its acceptability.
Source: PubMed
Designing a placebo device: involving service users in clinical trial design
Authors: Gooberman-Hill, R., Jinks, C., Boucas, S.B., Hislop, K., Dziedzic, K.S., Rhodes, C., Burston, A. and Adams, J.
Journal: HEALTH EXPECTATIONS
Volume: 16
Issue: 4
Pages: E100-E110
eISSN: 1369-7625
ISSN: 1369-6513
DOI: 10.1111/hex.12043
Source: Web of Science (Lite)
Designing a placebo device: involving service users in clinical trial design.
Authors: Gooberman-Hill, R., Jinks, C., Bouças, S.B., Hislop, K., Dziedzic, K.S., Rhodes, C., Burston, A. and Adams, J.
Journal: Health expectations : an international journal of public participation in health care and health policy
Volume: 16
Issue: 4
Pages: e100-e110
eISSN: 1369-7625
ISSN: 1369-6513
DOI: 10.1111/hex.12043
Abstract:Background
Service users are increasingly involved in the design of clinical trials and in product and device development. Service user involvement in placebo development is crucial to a credible and acceptable placebo for clinical trials, but such involvement has not yet been reported.Aims
To enhance the design of a future clinical trial of hand splints for thumb-base osteoarthritis (OA), service users were involved in splint selection and design of a placebo splint. This article describes and reflects on this process.Design
Two fora of service users were convened in 2011. Service users who had been prescribed a thumb splint for thumb-base OA were approached about involvement by Occupational Therapy (OT) practitioners.Content of the fora
A total of eight service users took part in the fora. Service users discussed their experience of OA and their own splints and then tried a variety of alternative splints. Through this they identified the active features of splints alongside acceptable and unacceptable design features. Service users focused on wearability and support with or without immobilization. Fora discussed whether a placebo group ('arm') was an acceptable feature of a future trial, and service users developed a potential design for a placebo splint.Conclusion and discussion
This is the first project that to involve service users in placebo design. Service users are increasingly involved in product and device design and are ideally placed to identify features to make a placebo credible yet lacking key active ingredients. The future trial will include research into its acceptability.Source: Europe PubMed Central